Eli Lilly's press release — LLY's reaction is being measured

LLY's realized reaction is still being measured.

· PR Newswire · Press release · Realized reaction, point-in-time, zero look-ahead.

Source headline

New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year

Via PR Newswire

How LLY reacted

Reaction is being measured.

This event is recent. News Quantified labels the realized price reaction once the trading sessions after the news complete — point-in-time, with zero look-ahead. The measured move will appear here, and below in LLY’s reaction history.

Which window

LLY’s news landed in the pre-market window; the main session closed +0.00%.

When it landedNews received 4:00 AM ET
  1. Mainprior session
  2. After-hours4:00 – 8:00 PM
  3. Overnightno tape
  4. Pre-market4:00 – 9:30 AM
  5. Main session9:30 AM – 4:00 PM

Segment widths are fixed, so two events on different days sit in comparable places. Hatched segments are real elapsed time with no tape to measure — the overnight halt is not a gap in the data.

Which window the move landed in1 of 4 windows measured
WindowWhat it answersAnchor priceResult
AllFrom the news to the first main-session close, across every session in between.1227.74re-anchored to the first print after the news+0.00%
After-hoursThe move between the closing bell and the overnight halt.—not measured
Pre-marketThe move between the pre-market open and the opening bell.—not measured
MainThe move inside the regular session, from the news to the close.—not measured

The main-session result is measured upstream against the price at the news; the all-sessions result is computed here from its own anchor and close, so the two can differ in the last decimal. After-hours and pre-market are measured upstream but populate on a small minority of events, so this page does not request them. Those rows are unmeasured, not empty.

What happened

Where this LLY event came from, and what the tape did with it.

Eli Lilly issued a press release, carried via PR Newswire, on Oct 15, 2026. It was the only Eli Lilly headline News Quantified labeled that day.

Against the price at the news timestamp, LLY's reaction is still being measured.

Context

How this compares to LLY’s usual reaction.

Across 2,000+ labeled events, LLY’s median 30-minute reaction to all news is +0.03% (52% up); by the close it is -0.07%.

Where this LLY event landedvs 2,000+ measured LLY reactions
LLYMiddle 50% · -0.57% to +0.60%Zero: 0.00%Median: +0.03%Median +0.03%-1.00%0+1.00%
Middle 50% of LLY reactions-0.57% to +0.60%
Median reaction (30-min)+0.03%
Measured reactions2,000+
Point-in-time · zero look-ahead

Half of all Eli Lilly news events land between -0.57% and +0.60% at 30 minutes; this one is a single draw from that distribution.

That’s the median — get an email the next time LLY moves on news →

You just saw one reaction. There are 26M+ more.

See the full LLY reaction history →
The record

What the LLY tape carried around this event.

The 20-day average true range into this session was 35.09. LLY carries no market-cap or price-to-earnings figure on this record, and no short interest, so none is shown.

Next time, know first

Email me when LLY moves on news.

One email per qualifying move — the headline, the measured reaction, and how it compares to LLY's baseline. Nothing else.

▲ LLY Free · unsubscribe anytime
26M+ news records Operating since 2012 Methodology on SSRN ↗
Similar LLY events

How comparable LLY events have landed.

Across 5 other recent Eli Lilly press release events, the median close-day reaction was -0.39%. Each is measured the same way, from its own news timestamp.

Go deeper

8 more LLY events, each measured the same way.

Recent LLY events, each with its measured reaction8
DateHeadline5-minTo close
Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study-0.65%-0.31%
New Phase 3b data show Lilly's EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand and foot atopic dermatitis+0.06%-2.48%
Lilly's Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparison+0.34%+0.15%
Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes+0.06%-2.48%
Lilly's Zepbound (tirzepatide 10 mg and 15 mg) was associated with more weight loss than Wegovy HD (semaglutide injection 7.2 mg) in a new indirect treatment comparison+0.34%+0.15%
Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICs+0.69%+0.39%
FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata+0.69%+0.39%
U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 diabetes+0.80%+2.00%
That same day, across the market4
Peer tickers, measured the same way4
Method

How the numbers are made.

How was LLY's 5-minute reaction measured?

From the news timestamp, not the trading day: News Quantified takes the last trade before this press release as the base price and measures the move five minutes of trading later — point-in-time, zero look-ahead. The same clock produced the to-close figure.

What is Eli Lilly's median reaction, and how does this event compare?

Eli Lilly's median is drawn from 2,000+ labeled events; at 30 minutes it sits at +0.03%, and -0.07% by the close. This event's move is one draw from that distribution — ordinary or outlier, the chart's median ticks show which.

Only one Eli Lilly headline was labeled Oct 15, 2026. How is it isolated?

It was the only Eli Lilly headline labeled that day, so its window has no same-day overlap — the move is measured cleanly from its own timestamp.

Does a measured reaction predict Eli Lilly's next reaction?

No. a measured reaction is a realized fact about Oct 15, 2026, not a forecast. Past reactions describe a distribution; they say nothing certain about any future move.

Cite this data

How to cite this reaction.

News Quantified. "New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year." LLY realized price reaction, Oct 15, 2026. Retrieved from https://newsquantified.com/tickers/lly/news/new-composite-outcomes-data-show-patients-treated-with-2026-10-15

Canonical URL: https://newsquantified.com/tickers/lly/news/new-composite-outcomes-data-show-patients-treated-with-2026-10-15

Query this dataset via the API & MCP →
Stop guessing what the event means

You just saw one reaction.
There are 26 million more.

For investors

Know the next move, measured.

Ticker alerts with the realized reaction — not the headline spin.

Free · no credit card · unsubscribe anytime
For builders

The dataset, one command away.

claude mcp add news-quantified

Then ask Claude: “how does LLY react to downgrades?” — or pull it raw via REST.

60-second signup on the NQ portal · 100 free credits/mo
26M+ news records, 2006–2026 Operating since 2012 Point-in-time, zero look-ahead Peer-reviewable methodology (SSRN) ↗